| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.7 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |